Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 20156960)

1.

Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.

Cook ED, Arnold KB, Hermos JA, McCaskill-Stevens W, Moody-Thomas S, Probstfield JL, Hamilton SJ, Campbell RD, Anderson KB, Minasian LM.

Clin Trials. 2010 Feb;7(1):90-9. doi: 10.1177/1740774509357227.

2.

Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Cook ED, Moody-Thomas S, Anderson KB, Campbell R, Hamilton SJ, Harrington JM, Lippman SM, Minasian LM, Paskett ED, Craine S, Arnold KB, Probstfield JL.

Clin Trials. 2005;2(5):436-42.

PMID:
16315648
3.

Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention.

Dunn BK, Ryan A, Ford LG.

Recent Results Cancer Res. 2009;181:183-93. Review.

PMID:
19213568
4.

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9.

5.

SELECT: the selenium and vitamin E cancer prevention trial.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

Urol Oncol. 2003 Jan-Feb;21(1):59-65. Review.

PMID:
12684129
6.

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr.

J Natl Cancer Inst. 2005 Jan 19;97(2):94-102.

7.

Selenium and vitamin E cancer prevention trial.

Klein EA.

Ann N Y Acad Sci. 2004 Dec;1031:234-41. Review.

PMID:
15753149
8.

Moving a randomized clinical trial into an observational cohort.

Goodman PJ, Hartline JA, Tangen CM, Crowley JJ, Minasian LM, Klein EA, Cook ED, Darke AK, Arnold KB, Anderson K, Yee M, Meyskens FL, Baker LH.

Clin Trials. 2013 Feb;10(1):131-42. doi: 10.1177/1740774512460345. Epub 2012 Oct 12.

9.

Minority recruitment in the prostate cancer prevention trial.

Moinpour CM, Atkinson JO, Thomas SM, Underwood SM, Harvey C, Parzuchowski J, Lovato LC, Ryan AM, Hill MS, Deantoni E, Gritz ER, Thompson IM Jr, Coltman CA Jr.

Ann Epidemiol. 2000 Nov;10(8 Suppl):S85-91.

PMID:
11189097
10.

Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial.

Chlebowski RT, Menon R, Chaisanguanthum RM, Jackson DM.

Clin Trials. 2010 Dec;7(6):744-8. doi: 10.1177/1740774510383886. Epub 2010 Sep 10.

PMID:
20833684
11.

Selenium and Vitamin E Cancer Prevention Trial--this one's for us.

Cook ED.

J Natl Med Assoc. 2002 Sep;94(9):856-8. No abstract available.

12.

The recruitment of African-Americans to cancer prevention and control studies.

Paskett ED, DeGraffinreid C, Tatum CM, Margitić SE.

Prev Med. 1996 Sep-Oct;25(5):547-53.

PMID:
8888322
13.

Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.

Pak RW, Lanteri VJ, Scheuch JR, Sawczuk IS.

Integr Cancer Ther. 2002 Dec;1(4):338-44. Review.

PMID:
14664728
14.

The selenium and vitamin E cancer prevention trial.

Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

World J Urol. 2003 May;21(1):21-7. Epub 2003 Mar 8. Review.

PMID:
12756490
15.

Prostate cancer prevention: what do we know now and when will we know more?

Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B.

Clin Prostate Cancer. 2003 Mar;1(4):215-20. Review.

PMID:
15040879
16.

Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.

Dew A, Khan S, Babinski C, Michel N, Heffernan M, Stephan S, Jordan N, Jovanovic B, Carney P, Bergan R.

Clin Trials. 2013 Apr;10(2):292-9. doi: 10.1177/1740774512471452. Epub 2013 Jan 15.

PMID:
23321266
17.

Factors affecting older african american women's decisions to join the PLCO Cancer Screening Trial.

Trauth JM, Jernigan JC, Siminoff LA, Musa D, Neal-Ferguson D, Weissfeld J.

J Clin Oncol. 2005 Dec 1;23(34):8730-8.

18.
19.

Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.

Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR.

Clin Trials. 2011 Apr;8(2):214-23. doi: 10.1177/1740774510396742. Epub 2011 Jan 17.

20.

SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.

Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C.

J Urol. 2001 Oct;166(4):1311-5.

PMID:
11547064
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk